Inhibition of Efferocytosis by Extracellular CIRP-Induced Neutrophil Extracellular Traps.
Kehong ChenAtsushi MuraoAdnan ArifSatoshi TakizawaHui JinJianxin JiangMonowar AzizPing WangPublished in: Journal of immunology (Baltimore, Md. : 1950) (2020)
Phagocytic clearance of apoptotic cells by the macrophages (efferocytosis) is impaired in sepsis, but its mechanism is poorly understood. Extracellular cold-inducible RNA-binding protein (eCIRP) is a novel damage-associated molecular pattern that fuels inflammation. We identify that eCIRP-induced neutrophil extracellular traps (NETs) impair efferocytosis through a novel mechanism. Coculture of macrophages and apoptotic thymocytes in the presence of recombinant murine CIRP (rmCIRP)-induced NETs significantly inhibited efferocytosis. Efferocytosis was significantly inhibited in the presence of rmCIRP-treated wild-type (WT), but not PAD4-/- neutrophils. Efferocytosis in the peritoneal cavity of rmCIRP-injected PAD4-/- mice was higher than WT mice. Milk fat globule-EGF-factor VIII (MFG-E8), an opsonin, increased macrophage efferocytosis, whereas the inhibition of efferocytosis by NETs was not rescued upon addition of MFG-E8, indicating disruption of MFG-E8's receptor(s) αvβ3 or αvβ5 integrin by the NETs. We identified neutrophil elastase in the NETs significantly inhibited efferocytosis by cleaving macrophage surface integrins αvβ3 and αvβ5 Using a preclinical model of sepsis, we found that CIRP-/- mice exhibited significantly increased rate of efferocytosis in the peritoneal cavity compared with WT mice. We discovered a novel role of eCIRP-induced NETs to inhibit efferocytosis by the neutrophil elastase-dependent decrease of αvβ3/αvβ5 integrins in macrophages. Targeting eCIRP ameliorates sepsis by enhancing efferocytosis.
Keyphrases
- wild type
- high glucose
- diabetic rats
- intensive care unit
- oxidative stress
- adipose tissue
- high fat diet induced
- cell death
- binding protein
- stem cells
- endothelial cells
- insulin resistance
- cell proliferation
- bone marrow
- mesenchymal stem cells
- metabolic syndrome
- growth factor
- drug delivery
- signaling pathway
- skeletal muscle
- cell free
- nucleic acid